GL1X · GenesisL1 explorer

Research workbench

Human alpha-thrombin complexed with ac-(D)PHE-pro-boro-N- butyl-amidino-glycine-oh

Analyse Human alpha-thrombin complexed with ac-(D)PHE-pro-boro-N… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1LHE
Type
protein
Length
282 residues
Chains
3
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-thrombin; Hirudin
EC
3.4.21.5
UniProt
P00734
Ligands
DI3
Pockets
2 · best druggability 0.56

Structure

x-ray diffraction · 3 distinct chains · 15% helix, 31% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
LAlpha-thrombin (EC 3.4.21.5)protein2631% helix, 0% strandP00734
HAlpha-thrombin (EC 3.4.21.5)protein24914% helix, 35% strandP00734
IHirudinprotein70% helix, 0% strand—

Ligands and binding sites

  • DI3 · Ac-(d)phe-pro-boro-N-butyl-amidino-glycine-oh · ligand · chains H

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

2 pockets found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
12510.560.7739DI3
2580.340.7816empty

Interfaces

2 interfaces between chains.

  • L–H · 1116 Ų buried · 26 hydrogen bonds · protein-protein
  • H–I · 470 Ų buried · 6 hydrogen bonds · protein-protein

Modifications

Observed in the structure: 4 disulfide, 1 covalent (disulfide, covalent ligand).

Compared structures

  • 1LHE · Human alpha-thrombin complexed with ac-(D)PHE-pro-boro-N-butyl-amidino-glycine-oh · the same entry in another collection · chain L against L, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.